Skip to main content
NCBI home page
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1989 Apr;33(4):407–411. doi: 10.1128/aac.33.4.407

Reappraisal of the antistaphylococcal activities of first-generation (narrow-spectrum) and second-generation (expanded-spectrum) cephalosporins.

L D Sabath 1
PMCID: PMC172450  PMID: 2658789

Full text

PDF
407

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Beam T. R., Raab T. A., Spooner J. A., Balderman S. C., Aldridge J., Bahyana J. N. Comparison of ceftriaxone and cefazolin prophylaxis against infection in open heart surgery. Am J Surg. 1984 Oct 19;148(4A):8–14. [PubMed] [Google Scholar]
  2. Bryant R. E., Alford R. H. Unsuccessful treatment of staphylococcal endocarditis with cefazolin. JAMA. 1977 Feb 7;237(6):569–570. [PubMed] [Google Scholar]
  3. Chapman S. W., Steigbigel R. T. Staphylococcal beta-lactamase and efficacy of beta-lactam antibiotics: in vitro and in vivo evaluation. J Infect Dis. 1983 Jun;147(6):1078–1089. doi: 10.1093/infdis/147.6.1078. [DOI] [PubMed] [Google Scholar]
  4. DiPiro J. T., Bowden T. A., Jr, Hooks V. H., 3rd Prophylactic parenteral cephalosporins in surgery. Are the newer agents better? JAMA. 1984 Dec 21;252(23):3277–3279. [PubMed] [Google Scholar]
  5. Farrar W. E., Jr, Gramling P. K. Antistaphylococcal activity and beta-lactamase resistance of newer cephalosporins. J Infect Dis. 1976 Jun;133(6):691–695. doi: 10.1093/infdis/133.6.691. [DOI] [PubMed] [Google Scholar]
  6. Fitzgerald R. H., Jr, Jones D. R. Hip implant infection. Treatment with resection arthroplasty and late total hip arthroplasty. Am J Med. 1985 Jun 28;78(6B):225–228. doi: 10.1016/0002-9343(85)90389-4. [DOI] [PubMed] [Google Scholar]
  7. Fong I. W., Engelking E. R., Kirby W. M. Relative inactivation by Staphylococcus aureus of eight cephalosporin antibiotics. Antimicrob Agents Chemother. 1976 Jun;9(6):939–944. doi: 10.1128/aac.9.6.939. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Frongillo R. F., Donati L., Federico G., Martino P., Moroni M., Ortona L., Palumbo M., Pasticci B. M., Pizzigallo E., Privitera G. Clinical comparative study on the activity of cefamandole in the treatment of serious staphylococcal infections caused by methicillin-susceptible and methicillin-resistant strains. Antimicrob Agents Chemother. 1986 May;29(5):789–796. doi: 10.1128/aac.29.5.789. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Gentry L. O., Zeluff B. J., Cooley D. A. Antibiotic prophylaxis in open-heart surgery: a comparison of cefamandole, cefuroxime, and cefazolin. Ann Thorac Surg. 1988 Aug;46(2):167–171. doi: 10.1016/s0003-4975(10)65890-0. [DOI] [PubMed] [Google Scholar]
  10. Hill C., Flamant R., Mazas F., Evrard J. Prophylactic cefazolin versus placebo in total hip replacement. Report of a multicentre double-blind randomised trial. Lancet. 1981 Apr 11;1(8224):795–796. doi: 10.1016/s0140-6736(81)92678-7. [DOI] [PubMed] [Google Scholar]
  11. Horan T. C., White J. W., Jarvis W. R., Emori T. G., Culver D. H., Munn V. P., Thornsberry C., Olson D. R., Hughes J. M. Nosocomial infection surveillance, 1984. MMWR CDC Surveill Summ. 1986;35(1):17SS–29SS. [PubMed] [Google Scholar]
  12. KJELLANDER J. O., FINLAND M. STUDIES ON THE PENICILLINASE OF STAPHYLOCOCCUS ALBUS. Proc Soc Exp Biol Med. 1963 Aug-Sep;113:1031–1037. doi: 10.3181/00379727-113-28564. [DOI] [PubMed] [Google Scholar]
  13. Kaiser A. B., Clayson K. R., Mulherin J. L., Jr, Roach A. C., Allen T. R., Edwards W. H., Dale W. A. Antibiotic prophylaxis in vascular surgery. Ann Surg. 1978 Sep;188(3):283–289. doi: 10.1097/00000658-197809000-00003. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Kaiser A. B., Petracek M. R., Lea J. W., 4th, Kernodle D. S., Roach A. C., Alford W. C., Jr, Burrus G. R., Glassford D. M., Jr, Thomas C. S., Jr, Stoney W. S. Efficacy of cefazolin, cefamandole, and gentamicin as prophylactic agents in cardiac surgery. Results of a prospective, randomized, double-blind trial in 1030 patients. Ann Surg. 1987 Dec;206(6):791–797. doi: 10.1097/00000658-198712000-00018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Karchmer A. W. Staphylococcal endocarditis. Laboratory and clinical basis for antibiotic therapy. Am J Med. 1985 Jun 28;78(6B):116–127. doi: 10.1016/0002-9343(85)90374-2. [DOI] [PubMed] [Google Scholar]
  16. Kini P. M., Fernandez J., Causay R. S., Lemole G. M. Double-blind comparison of cefazolin and cephalothin in open-heart surgery. J Thorac Cardiovasc Surg. 1978 Oct;76(4):506–509. [PubMed] [Google Scholar]
  17. Laverdiere M., Peterson P., Verhoef J., Williams D. N., Sabath L. D. In vitro activity of cephalosporins against methicillin-resistant, coagulase-negative staphylococci. J Infect Dis. 1978 Mar;137(3):245–250. doi: 10.1093/infdis/137.3.245. [DOI] [PubMed] [Google Scholar]
  18. Miley G. B., Scheller A. D., Jr, Turner R. H. Medical and surgical treatment of the septic hip with one-stage revision arthroplasty. Clin Orthop Relat Res. 1982 Oct;(170):76–82. [PubMed] [Google Scholar]
  19. Mészáros R., Windisch M., Koltai C., Lukács L. Comparative study of cefamandole versus cephalothin as antibiotic prophylaxis for open heart surgery. Cor Vasa. 1986;28(1):61–66. [PubMed] [Google Scholar]
  20. Parr G. V., Aber R. C. Comparative efficacy and tolerance of cefamandole and cephalothin as prophylaxis for open heart surgery: a randomized double-blind study. J Cardiovasc Surg (Torino) 1982 Jul-Aug;23(4):305–308. [PubMed] [Google Scholar]
  21. Peters G., Pulverer G. Pathogenesis and management of Staphylococcus epidermidis 'plastic' foreign body infections. J Antimicrob Chemother. 1984 Dec;14 (Suppl 500):67–71. doi: 10.1093/jac/14.suppl_d.67. [DOI] [PubMed] [Google Scholar]
  22. Quinn E. L., Pohlod D., Madhavan T., Burch K., Fisher E., Cox F. Clinical experiences with cefazolin and other cephalosporins in bacterial endocarditis. J Infect Dis. 1973 Oct;128(Suppl):S386–S389. doi: 10.1093/infdis/128.supplement_2.s386. [DOI] [PubMed] [Google Scholar]
  23. RICHMOND M. H. WILD-TYPE VARIANTS OF EXOPENICILLINASE FROM STAPHYLOCOCCUS AUREUS. Biochem J. 1965 Mar;94:584–593. doi: 10.1042/bj0940584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Regamey C., Libke R. D., Engelking E. R., Clarke J. T., Kirby M. M. Inactivation of cefazolin, cephaloridine, and cephalothin by methicillin-sensitive and methicillin-resistant strains of Staphylococcus aureus. J Infect Dis. 1975 Mar;131(3):291–294. doi: 10.1093/infdis/131.3.291. [DOI] [PubMed] [Google Scholar]
  25. Sabath L. D., Garner C., Wilcox C., Finland M. Effect of inoculum and of beta-lactamase on the anti-staphylococcal activity of thirteen penicillins and cephalosporins. Antimicrob Agents Chemother. 1975 Sep;8(3):344–349. doi: 10.1128/aac.8.3.344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Sheagren J. N. Staphylococcus aureus. The persistent pathogen (second of two parts). N Engl J Med. 1984 May 31;310(22):1437–1442. doi: 10.1056/NEJM198405313102206. [DOI] [PubMed] [Google Scholar]
  27. Slama T. G., Sklar S. J., Misinski J., Fess S. W. Randomized comparison of cefamandole, cefazolin, and cefuroxime prophylaxis in open-heart surgery. Antimicrob Agents Chemother. 1986 May;29(5):744–747. doi: 10.1128/aac.29.5.744. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Woods G. L., Knapp C. C., Washington J. A., 2nd Relationship between cefamandole and cefuroxime activity against oxacillin-resistant Staphylococcus epidermidis and oxacillin resistance phenotype. Antimicrob Agents Chemother. 1987 Sep;31(9):1332–1337. doi: 10.1128/aac.31.9.1332. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES